Cannerald
Cannerald AG is a privately held Swiss medical cannabis producer founded in 2017 that cultivates pharmaceutical-grade cannabis flower through indoor vertical farming, selling B2B to pharmacies, healthcare providers, and international distributors while pursuing EU GMP certification.
- Company typePrivate
- Founded2017
- HeadquartersFraubrunnen, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cannerald does
Cannerald AG is a privately held Swiss medical cannabis producer founded in 2017 by Sascha, Levin, and Severin in Fraubrunnen, Canton Bern. The company cultivates pharmaceutical-grade dried cannabis flower using indoor vertical farming, managing the full production chain across mother rooms, baby rooms, 25 hi-tech flower rooms, drying rooms, and on-site laboratories within a 10,300 m² facility capable of holding 32,500 active plants and producing up to 20 tons annually. Cultivation relies on controlled environment agriculture hardware including Fluence LED lighting, 100% hydroelectric power, a heat recovery system (with surplus heat resale), and activated carbon air filtration with 90% air recirculation.
The core commercial offering is a single product category — premium Swiss-grown medical cannabis flowers — sold B2B to pharmacies, healthcare providers, and international distributors under a sales-led, quote-based pricing model. Three dedicated email channels (Carrier & Delivery, B2B Inquiries, Applications) support enterprise onboarding. Cannerald is actively pursuing EU GMP and GACP certification to access full pharmaceutical channels, and markets itself on 'Swiss Made' quality positioning supported by an educational content engine of 70+ blog articles plus active presence on LinkedIn, Instagram, X, and YouTube.
Cannerald operates two registered Swiss locations — the Fraubrunnen (Canton Bern) headquarters containing cultivation and production, and a Pfäffikon SZ (Canton Schwyz) registered office — and claims global client reach while remaining pre-GMP and privately founder-financed, with no disclosed funding rounds, revenue, or institutional investment in the available data.
Cannerald firmographics
Firmographics- Name
- Cannerald
- Legal name
- Cannerald AG
- Website
- https://cannerald.ch
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cannerald AG is a privately held Swiss medical cannabis producer founded in 2017 that cultivates pharmaceutical-grade cannabis flower through indoor vertical farming, selling B2B to pharmacies, healthcare providers, and international distributors while pursuing EU GMP certification.
- Ownership category
- akta.pro rank
Cannerald industry classification
Industry- Product category
- Medical Cannabis Production
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)
Keywords
Where Cannerald is headquartered
LocationHeadquarters
- HQ city
- Fraubrunnen
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Cannerald business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Infrastructure, Technology or R&D, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Medical Cannabis Product Sales: Revenue generated from the sale of premium medical cannabis products cultivated in Switzerland. Products include dried cannabis flowers produced through their indoor vertical farming operations, targeting B2B clients including pharmacies and healthcare providers worldwide.
- B2B Wholesale & Supply Agreements: Direct B2B sales relationships with medical cannabis distributors, pharmacies, and healthcare institutions. Company has dedicated contact channels for B2B inquiries and carrier/delivery services.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Cannerald product offering
Product offeringCore offering
Cannerald cultivates and produces pharmaceutical-grade medical cannabis flower products in Switzerland through advanced indoor vertical farming. The company manages the complete production cycle from mother and baby rooms through vegetative growth, flowering, drying, trimming, and laboratory testing, and sells the output on a B2B basis to pharmacies, healthcare providers, and international distributors. It is pursuing GMP and GACP certification to align with the strictest pharmaceutical standards in the industry.
Product overview
Cannerald is a Swiss medical cannabis company operating as a single unified product offering — premium medical cannabis flower products. The company cultivates cannabis through advanced indoor vertical farming facilities, managing every stage from mother rooms through baby rooms, vegetative growth, flowering, drying, trimming, and laboratory testing. They are pursuing GMP and GACP certification to meet pharmaceutical-grade quality standards. The portfolio consists primarily of their core medical cannabis flower product, with no modular add-ons or separate product lines identified.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical-Grade Medical Cannabis Pharmaceutical-grade medical cannabis flower products cultivated in Switzerland through indoor vertical farming, sold B2B to pharmacies, healthcare providers, and international distributors. Includes precise cannabinoid analysis, stability testing, and full traceability from seed to harvest, with a 20 ton annual capacity target supported by GMP/GACP compliance preparation.
Quantifiable outcome
- Consistent pharmaceutical-grade quality through rigorous controls
- +2 more outcomes
Companies that use Cannerald
Customer profileSegments3 records
Ideal customer profiles2 records
Cannerald technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cannerald partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights5 records
Cannerald competitors and assessment
Company assessmentDirect peers
- Bedrocan: Dutch government-contracted producer of standardized pharmaceutical-grade medical cannabis flower. Closest functional analogue to Cannerald: cultivates indoors, sells to pharmacies internationally, and emphasizes batch-to-batch consistency.
- DEMECAN: German medical cannabis cultivator and distributor serving the domestic pharmacy channel. Direct peer competing for the same EU-GMP certified European wholesale market Cannerald is targeting.
- Linnea SA: Swiss-based medical cannabis producer supplying the domestic and EU markets. Direct geographic and product peer to Cannerald, both targeting GMP-grade flower from Swiss facilities.
- Cannalpina: Swiss medical cannabis cultivation startup based near Bern. Closest home-market peer competing directly for Swiss production permits and European offtake.
Broad incumbents
- Pure Sunfarms: Canadian greenhouse medical cannabis producer with EU export reach. Broad incumbent demonstrating the greenhouse-vs-vertical-indoor cultivation comparison relevant to Cannerald's positioning.
- Aurora Cannabis: Canadian-licensed producer with European medical cannabis distribution. Broad incumbent with GMP-certified indoor cultivation that competes for the same wholesale buyers.
- Aphria / Tilray Medical: Established medical cannabis supplier to German pharmacies through EU-GMP facilities. Incumbent peer whose supply Cannerald must displace or complement in European tenders.
- OrganiGram Holdings: Canadian licensed producer with EU-GMP medical cannabis supply contracts. Broad incumbent that exports into the same European markets Cannerald serves.
- Tilray Brands: Global cannabis incumbent with EU-GMP medical cannabis operations in Germany and Portugal. Broad incumbent selling pharmaceutical-grade flower into the same European pharmacy channels Cannerald is targeting.
Emerging players
- Wayland Group / Maricann: Canadian-German medical cannabis producer with EU-GMP operations. Emerging cross-border peer similarly focused on the German pharmacy channel with indoor cultivation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cannerald social profiles
Digital presenceCannerald financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cannerald leadership team
Management profileNumber of profiles
Profiles4 records
Cannerald funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cannerald M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cannerald
What does Cannerald do?
Cannerald cultivates and produces pharmaceutical-grade medical cannabis flower products in Switzerland through advanced indoor vertical farming. The company manages the complete production cycle from mother and baby rooms through vegetative growth, flowering, drying, trimming, and laboratory testing, and sells the output on a B2B basis to pharmacies, healthcare providers, and international distributors. It is pursuing GMP and GACP certification to align with the strictest pharmaceutical standards in the industry.
Is Cannerald a public or private company?
Cannerald is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cannerald founded?
Cannerald was founded in 2017. It employs 11 to 50 people.
Where is Cannerald based?
Cannerald is headquartered in Fraubrunnen, Switzerland, in the Europe region.
How does Cannerald make money?
Two revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are B2B Wholesale & Supply Agreements.
Who are Cannerald's main competitors?
Direct peers on record are Bedrocan, DEMECAN, Linnea SA and Cannalpina. Broad incumbents are Pure Sunfarms, Aurora Cannabis, Aphria / Tilray Medical, OrganiGram Holdings and Tilray Brands. Wayland Group / Maricann is listed as an emerging player.
Does Cannerald have an API?
No public API is recorded for Cannerald.
What industry is Cannerald in?
Cannerald's product category is Medical Cannabis Production. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its NAICS code is 325411 and its SIC code is 2833.